Joshua I Daum

Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade

B. Necela, K. Knutson, M. Cannon, 2023, Journal for ImmunoTherapy of Cancer.